08/02/2016

Biosystems International Kft. completed H2020 SME Instrument Phase 1 and the European Commission honored Cancer Diagnosis by Multiplex Protein Epitope Profiling (CANDLE) proposal with Seal of Excellence.

22/11/2015

BIOSYSTEMS INTERNATIONAL AND RANDOX LABORATORIES ANNOUNCE COMPLETION OF CLINICAL TRIAL AND LICENSING FOR QUANTIPLASMA ANTIBODIES FOR EARLY LUNG CANCER DIAGNOSTICS

Biosystems International and Randox Laboratories today announced the beginning of clinical validation of a lung cancer early detection test

CRUMLIN, NORTHERN IRELAND / DEBRECEN, HUNGARY (PRWEB) November 22, 2015

http://www.prweb.com/releases/2015/11/prweb13096783.htm

07/10/2015

4th Biomarkers in Diagnostics Conference, October 7-8, 2015 in Berlin, Germany Laszlo Takacs CEO and CSO of Biosystems International Kft. chaired the opening session and presented BSI.

07/09/2015

IV International Caparica Conference on Analytical Proteomics, September 7-9, 2015 Caparica, Portugal. Laszlo Takacs, CEO/ CSO presented the latest technology advances.

01/09/2015

5th International Conference on Proteomics & Bioinformatics September 01-03, 2015 Valencia, Spain. Jozsef Lazar presented BSI translational research results.

01/09/2015

Biosystems International Kft. wins Horizon 2020 SME Instrument Phase I support for the feasibility study of Cancer Diagnosis by Multiplex Protein Epitope Profiling (CANDLE) project.

https://ec.europa.eu/easme/en/sme/6401/cancer-diagnosis-multiplex-protein-epitope-profiling

17/04/2012

Roche Diagnostics GmbH purchased the first version of BSI’s lung cancer diagnostics mAb panel and corresponding patents.

Roche Diagnostics GmbH purchased BSI’s COPD biomarker and drug target patent.